Kalaris Therapeutics Inc

KLRS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$118,289$3,169$3,059$201,661
Short-Term Investments$0$0$0$46,459
Receivables$0$0$0$50
Inventory$0$0$0$0
Other Curr. Assets$257$164$840$5,178
Total Curr. Assets$118,546$3,333$3,899$253,348
Property Plant & Equip (Net)$0$0$0$31,292
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$852
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$1,102
Total NC Assets$0$0$0$33,246
Other Assets$0$0$0$0
Total Assets$118,546$3,333$3,899$286,594
Liabilities
Payables$247$2,362$2,759$8,361
Short-Term Debt$0$0$0$6,591
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,992$1,580$2,932$22,901
Total Curr. Liab.$5,239$3,942$5,691$37,853
LT Debt$0$0$3,253$23,475
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$44,408$25,227$0
Total NC Liab.$0$44,408$28,480$23,475
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$23,475
Total Liabilities$5,239$48,350$34,171$61,328
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$7
Retained Earnings-$714,962-$47,394-$32,695-$297,065
AOCI-$135$0$0-$155
Other Equity$828,404$2,377$2,423$522,479
Total Equity$113,307-$45,017-$30,272$225,266
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$118,546$3,333$3,899$286,594
Net Debt-$118,289-$3,169$194-$171,595